Short course of oral lithium therapy as an adjunct in patients with thyrotoxicosis who failed initial radioiodine therapy: Should this be worthwhile to consider in the absence of contraindications?
dc.contributor.author | Basu, Sandip | |
dc.contributor.author | Abhyankar, A. | |
dc.date.accessioned | 2018-01-16T09:33:54Z | |
dc.date.available | 2018-01-16T09:33:54Z | |
dc.date.issued | 2017 | |
dc.description.division | RMC | en |
dc.format.extent | 3351 bytes | |
dc.format.mimetype | text/html | |
dc.identifier.source | Nuclear Medicine Communications, 2017. Vol. 38 (8): pp. 726-727 | en |
dc.identifier.uri | http://hdl.handle.net/123456789/15524 | |
dc.language.iso | en | en |
dc.subject | Short course | en |
dc.subject | oral lithium therapy | en |
dc.subject | thyrotoxicosis | en |
dc.subject | initial radioiodine therapy | en |
dc.subject | contraindications | en |
dc.title | Short course of oral lithium therapy as an adjunct in patients with thyrotoxicosis who failed initial radioiodine therapy: Should this be worthwhile to consider in the absence of contraindications? | en |
dc.type | Article | en |